Literature DB >> 32650256

Past, present and future of proton therapy for head and neck cancer.

Xingzhe Li1, Anna Lee1, Marc A Cohen2, Eric J Sherman3, Nancy Y Lee4.   

Abstract

Proton therapy has recently gained substantial momentum worldwide due to improved accessibility to the technology and sustained interests in its advantage of better tissue sparing compared to traditional photon radiation. Proton therapy in head and neck cancer has a unique advantage given the complex anatomy and proximity of targets to vital organs. As head and neck cancer patients are living longer due to epidemiological shifts and advances in treatment options, long-term toxicity from radiation treatment has become a major concern that may be better mitigated by proton therapy. With increased utilization of proton therapy, new proton centers breaking ground, and as excitement about the technology continue to increase, we aim to comprehensively review the evidence of proton therapy in major subsites within the head and neck, hoping to facilitate a greater understanding of the full risks and benefits of proton therapy for head and neck cancer.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32650256     DOI: 10.1016/j.oraloncology.2020.104879

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

Review 1.  Advances in Organ Preservation for Laryngeal Cancer.

Authors:  Graham Campbell; Tiffany A Glazer; Randall J Kimple; Justine Yang Bruce
Journal:  Curr Treat Options Oncol       Date:  2022-03-18

2.  Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck.

Authors:  Yuying Zhu; Shikang Zheng; Xingyou Zhai; Cheng Wang; Aijun Liu; Jun Ju; Xin Peng; Liwei Chen; Yongxia Zhang; Nan Ren; Yingli Xie; Junda Fan; Kai Zhao; Mingbo Liu
Journal:  J Immunol Res       Date:  2022-04-18       Impact factor: 4.493

3.  A Decision Support Tool to Optimize Selection of Head and Neck Cancer Patients for Proton Therapy.

Authors:  Makbule Tambas; Hans Paul van der Laan; Arjen van der Schaaf; Roel J H M Steenbakkers; Johannes Albertus Langendijk
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

4.  Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy.

Authors:  Irini Youssef; Jennifer Yoon; Nader Mohamed; Kaveh Zakeri; Robert H Press; Yao Yu; Jung Julie Kang; Richard J Wong; R Michael Tuttle; Ashok Shaha; Eric Sherman; Nancy Y Lee
Journal:  Int J Part Ther       Date:  2022-07-15

5.  Head and Neck Cancer Types and Risks of Cervical-Cranial Vascular Complications within 5 Years after Radiation Therapy.

Authors:  Chi-Hung Liu; Bing-Shen Huang; Chien-Yu Lin; Chih-Hua Yeh; Tsong-Hai Lee; Hsiu-Chuan Wu; Chien-Hung Chang; Ting-Yu Chang; Kuo-Lun Huang; Jian-Lin Jiang; Joseph Tung-Chieh Chang; Yeu-Jhy Chang
Journal:  J Pers Med       Date:  2022-06-29

6.  Beam-Specific Spot Guidance and Optimization for PBS Proton Treatment of Bilateral Head and Neck Cancers.

Authors:  Karla Leach; Shikui Tang; Jared Sturgeon; Andrew K Lee; Ryan Grover; Parag Sanghvi; James Urbanic; Chang Chang
Journal:  Int J Part Ther       Date:  2021-06-25

7.  Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.

Authors:  Xingzhe Li; Sarin Kitpanit; Anna Lee; Dennis Mah; Kevin Sine; Eric J Sherman; Lara A Dunn; Loren S Michel; James Fetten; Kaveh Zakeri; Yao Yu; Linda Chen; Jung Julie Kang; Daphna Y Gelblum; Sean M McBride; Chiaojung J Tsai; Nadeem Riaz; Nancy Y Lee
Journal:  JAMA Netw Open       Date:  2021-06-01

8.  High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations.

Authors:  Dong Woo Lee; Jung Eun Kim; Ga-Haeng Lee; Arang Son; Hee Chul Park; Dongryul Oh; Kwanghyun Jo; Changhoon Choi
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.